Home/All Molecules/Rutoside

Rutoside Range

Comprehensive Rutoside portfolio for Franchise & Manufacturing.

Category
rutoside
Total Formulations
3
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Rutoside portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Rutoside batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Rutoside PCD Pharma Franchise

Rutoside PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Rutoside PCD pharma franchise company offering a portfolio of 3 Rutoside formulations across tablets. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Rutoside?

Rutoside (rutin) is a bioflavonoid with venotonic and capillary-protective properties. It reduces capillary permeability and fragility and has antioxidant and anti-oedema activity; in Indian practice it is most often supplied in fixed-dose combinations with trypsin, bromelain or diclofenac as an anti-inflammatory and anti-oedema adjunct. The compound record can be reviewed on PubChem.

Therapeutic Applications

Post-traumatic and post-surgical soft-tissue swelling, sprains and sports injuries, chronic venous insufficiency and haemorrhoidal symptoms, and inflammatory oedema in orthopaedic and dental practice, usually as part of an enzyme-flavonoid combination.

Prescribed by: Orthopaedic surgeons, dental surgeons, general and plastic surgeons, and physiotherapy-linked consultants prescribe Rutoside combinations; general physicians use them in soft-tissue injury.

Why Rutoside is a High-Potential Molecule for Distributors

Rutoside rarely sells on its own name and that is exactly its commercial strength: it rides on high-turnover enzyme combinations with trypsin, bromelain and diclofenac that orthopaedic and dental surgeons prescribe after almost every procedure or injury. Post-surgical and post-traumatic oedema is a constant, non-seasonal source of prescriptions, and because these packs are supportive therapy they are widely accepted and reordered. For a distributor with an orthopaedic or dental focus, the Rutoside combination range is a steady, low-resistance add-on to any analgesic line.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Rutoside franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Rutoside business in your region.

References

  1. PubChem – Rutoside compound record, US National Library of Medicine
  2. PubMed – clinical literature on Rutoside, NCBI

Aceclofenac in Modern Clinical Practice

Our formulations of Rutoside find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Rutoside in PCD Franchise

Start Your Rutoside Franchise with Cafoli Lifecare

Ready to take monopoly rights for Rutoside in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 3 Rutoside formulations in tablets. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Rutoside range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

Orthopaedic surgeons, dental surgeons, general and plastic surgeons, and physiotherapy-linked consultants prescribe Rutoside combinations; general physicians use them in soft-tissue injury.

In Indian practice Rutoside is prescribed almost entirely within fixed-dose combinations, most often with trypsin, bromelain or diclofenac, as an anti-oedema and anti-inflammatory adjunct after surgery, dental procedures and soft-tissue injury. Distributors therefore see it as a companion line to an orthopaedic or dental analgesic range rather than a standalone brand.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Rutoside franchise agreement and monopoly allotment can be processed.